Testing of CYP2C19 Variants and Platelet Reactivity for Guiding Antiplatelet Treatment - Research Review - Final | AHRQ Effective Health Care Program

full-text ►
Testing of CYP2C19 Variants and Platelet Reactivity for Guiding Antiplatelet Treatment - Research Review - Final | AHRQ Effective Health Care Program

Research Review - Final – Sept. 25, 2013

Testing of CYP2C19 Variants and Platelet Reactivity for Guiding Antiplatelet Treatment

Formats

• Report (without appendixes) (PDF) 5.0 MB  
• Appendixes (PDF) 10.9 MB  
• Help with Viewers, Players, and Plug-ins

This report is available in PDF only. (Report without appendixes, 5.0 MB; appendixes, 10.9 MB) People using assistive technology may not be able to fully access information in these files. For additional assistance, please contact us.